There is an increasing interest in measuring human plasma histamine levels in various clinical conditions. A variety of 'old' and newly developed techniques are applied to meet this demand. However, the discrepancy between reported reference values for histamine in human plasma measured using this variety of techniques, suggests the existence of a certain degree of inaccuracy and imprecision. We therefore organized an external quality control study on the reliability of current histamine determinations in European laboratories. Three lyophilized plasma quality control samples, in duplicate, covering the normal and pathological range of histamine concentrations {0-45 nmol/l), two different aqueous histamine standard samples and one solvent sample were sent to 10 laboratories for the analysis of their histamine content. The following methods were used: gas chromatography-mass spectrometry (« = 2), enzymatic single isotopic assay («= 1), fiuorometric-fluoroenzymatic assay (« = 3). radioimmunoassay (« = 3) and high performance liquid chromatography {n = 2). The study was performed and evaluated according to the approved recommendations (1983) ofthe International Federation of Clinical Chemistry (IFCC). The target values ±s.d. ofthe three plasma samples were: 39-5±4-6 nmol/l (CV=ll-6%), 2 3 + 2-2 nmo!/l (CV-96%) and 8-9+1-5 nmol/l (CV=17%), respectively. The target values +s.d. ofthe two aqueous samples were: 0-9± 1-1 nmol/l (CV= 120%; true value: 0 00 nmol/l) and 10 2±0-5nmol/l(CV=5 3%; true value: 10 Onmol/l), respectively. A Youden plot oftwo unrelated plasma samples in the pathological range defined 7/11 results as accurate and precise. The Youden plot of the two unrelated aqueous samples only defined 6/11 results as accurate and precise. In general, estimating histamine concentrations within the normal range seemed to be the most difficult part of measuring histamine in human plasma samples. It is suggested to define reference standards, methods and laboratories for plasma histamine determinations.
Introduction
Several assays have been developed, varying from bioassay, fluorometry. enzymatic assay, chromatography to radioimmunoassay [1 43] (Table I) , for studying endogenous histamine release in man. The determination of histamine concentrations in plasnia has important applications [14,20,21.27,30.43 54] ; because of the short halflife time of histamine (c. 2 min.) [55, 56] this is especially important in the field of controlled studies, in which it is possible to collect blood samples at regular times. However, in a meta-analysis evaluation about the role of histamine as a mediator in septic/endotoxic shock, threequarters of the relevant studies are quoted as being an unreliable assay for measuring histamine in human 349 [ [47, 56] , plasma and the authors conclude 'it is irrational to develop theories about any pathomechanism of histamine release before this error has been carefully excluded" [51] . Also the discrepancy between recently reported reference values for histamine in human plasma (Table 1: [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] ; n = 25: CV = 67%) suggests that besides possible sample collection problems [40] and biorhythmic differences [12] , inaccuracy and imprecision may exist, leading to unreliable reports. This thought has been confirmed in 1980 by Gleich and Hull [57] , who published a study in which 22 laboratories participated, and four different techniques for the measurement of histamine in plasma and buffered aqueous solutions containing known amounts of histamine were evaluated: enzymatic double isotopic assay, enzymatic single isotopic assay, automated fluorometric and manual fluorometric assay. There were several methodological pitfalls in the study of Gleich and Hull [57] . The variation in reported reference values, the increasing interest in measuring histamine, the improvements of'old' techniques and the development of new chromatographic and immunological methods inspired us to organize a renewed external quality control study on histamine measurement in plasma in European laboratories, covering five different techniques: gas chromatography-mass spectrometry (GCMS), enzymatic double isotopic assay (EDIA). fluorometric fluoroenzymatic assay (FFEA), radioimmunoassay (RIA) and high performance liquid chromatography (HPLC). For each technique two laboratories were selected.
This study was performed and evaluated according to the approved recommendations of the International Federation of Clinical Chemistry (IFCC), dealing on external quality-control studies in clinical chemistry [58] .
Our aims were to establish the ability of several laboratories using different techniques to obtain the same results in the same specimens, to provide an overall measure of inaccuracy and imprecision and to act as an educational stimulus to improve the performances by informing the laboratories about their results and to compare them with those of the other participating laboratories.
The results of this study were partly presented at the Munich Consensus Development Conference on Histamine Determination, December 3-7, 1988 [59, 60] and at the 18th Meeting ofthe European Histamine Research Society, May 17-20, 1989 , The Netherlands [61] .
Materials and methods

Materials
Reagents. Histamine dihydrochloride (extra pure) was purchased from Merck, Darmstadt, FRG; water (Baker High performance liquid chromatography [38] analysed HPLC® reagent) from JT Baker. Devcnter. The Netherlands; and hydrochloric acid 30% (Suprapur®) from Merck, Darmstadt, FRG.
Histamine stock solution. Histamine dihydrochloride was dried at 80 C for one night and cooled at room temperature in a desiccator for 5 hr. A portion was dried to a constant weight of 57 49 mg in a desiccator and dissolved in 250 ml of 01 mol/l hydrochloric acid. Exactly 1 ml of this solution was diluted further with 01 mol/l hydrochloric acid to 250 ml, resulting in a histamine stock solution containing 4 996 /tmol/1 histamine. This histamine stock solution was used to prepare aqueous and plasma histamine quality control samples.
Stability control. During the preparatory phase (see Methods) the effect of lyophilizing plasma samples and subsequent storage for 4 weeks at -1-4 C on their histamine concentration was studied by comparison with the histamine concentration obtained in the same plasma samples without lyophilization and storage for only a few days at -20°C. Twelve 5 ml portions of plasma containing three different amounts of histamine. between 0 and 60 nmol/I, were prepared by adding different amounts of a histamine stock solution to pooled human plasma (four portions of each concentration:
Six portions (two of each concentration: la, b, Ila, b and llla, b) were dispensed into 17-ml glass ampules and lyophilized overnight and sealed with butyl-rubber torches. After 4 weeks storage at -I-4'C, the content ofthe ampules was redissolved with water and the histamine concentration determined. The six remaining portions (two of each concentration: led, lie, d and 11 lc,d) were dispensed into polypropylene tubes, stored at -2O'C and analysed within the same week of preparation. All samples were analysed by GCMS [40, 48] . Plasma hi.ftamine preparation. Blood was collected frotn 13 volutiteers, usitig no medication at all (one female and 12 males, age 22-57 yr), by venepuncture in dry EDTAcontaining evacuated blood collection tubes of 10 ml (Venoject®, Terumo, Belgium). From the nine blood samples/volunteer the first one was always discarded. The samples were immediately cooled in melting ice {0-4"C) and plasma was prepared within 30 min after blood collection by centrifugation in a cooled centrifuge {-f-4'C) at 1000 Xj(f for 10 min. Using polypropylene pipettes the plasma was transferred to polypropylene tubes and centrifuged again for 10 min at 3000 xg in a cooled centrifuge {-|-4^C). The supernatants were pooled in a polypropylene container to give a final volume of approximate 360 ml. After gentle mixing this plasma pool was subdivided in three equal pools (I-III) in polypropylene containers and cooled.
Ptasma histatnine quality conlrol mniptes. Three different quality control samples were prepared. Quality control sample I was prepared by adding I ml (4')96 nmol histamine) and quality control sample 111 by adding 200 /il (0-999 nmoi histamine) of the histamine stock solution to plasma pool I and III. respectively. Quality control sample II consisted of plasma portion II without added histamine. Exactly 5-g portions (4-9979 + 0 0050; mean + s.d.) of the quality control samples I. II and III were dispensed into 17 ml glass ampules and coded. The 
. ( plasma samples were lyophilized overnight and sealed with a butyl-rubber torch. At the time of analysis the participants were asked to redissolve the contents into 5 ml distilled water (HPLC quality. Baker), to mix for 5 min and to analyse the resulting solutions for the histamine concentration.
Aqueous hislamine quality control samples. Two different quality control samples were prepared. The first one (sample IV) consisted only of 01 mol/1 hydrochloric acid with no exogenous histamine. Sample V was prepared by diluting 200 p\ of the histamine stock solution with 01 mol/1 hydrochloric acid to 100 ml to give a final concentration of 10 nmol/l histamine. Exactly 5 ml of both quality control samples were dispensed into 17-mI glass ampules and sealed with butyl-rubber torches.
Methods
Design of the study. A 3-month preparatory phase (JuneAugust 1988) was needed to design and start the study. This included (1) the preparatioti of the samples and their control for stability under field conditions (sec Materials), (2) the preparation of standardized and clear-cul instructions and report forms, including a questionnaire about the method used and (3) the selection of experienced participants and current methods with agreement to perform the analysis within 6 weeks. Each participating laboratory was provided by mail with (I) plasma samples I III in duplicate, (2) aqueous samples IV and V, (3) otie solvent sample (15 ml 0-1 mol/l hydrochloric acid, Suprapur® 30% in water; HPLC quality. Baker) and (4) instructions and report forms. No participant had information on the amount of histamine in the samples. The samples were only identified as plasma or aqueous samples.
In total, 10 European laboratories were asked to participate in this study, two for each analytical method: GCMS, HDIA, FFEA, RIA or HPLC.
Evaluation of the results.
The results were evaluated according to the recommendation on quality control in clinical chemistry given by the IFCC [58] . Target values According to IUPAC rules, the plasma histamine concentration is expressed in nmol/1, although we are aware ofthe fact that in many reports the old unit, ng/ml. still is used. The advantage of nmol/1 is that the base can not be mistaken with the salt. The conversion from nmol/l into ng/ml is multiplication by 0111.
Alt participating laboratories were informed about the results before using them for any kind of presentation. The results of each individual participant was and will remain strictly confidential.
Results
The difficulties that arise in a multicentre study like this, may be illustrated by the following facts. Only two participants reported their results within the specified time. The participants asked to analyse their samples with the EDIA technique were unable to run the method for different reasons; one of them used the FFEA and the other one the enzymatic single isotopic assay (ESIA). One laboratory used two methods. HPLC and RIA. for the same set of samples. For this reason we received 11 results all together. In Table 2 the 11 analytical methods, combined with the reference(s) as reported by the participants, are shown.
The mean histamine concentrations in the three duplicate plasma samples after (1) lyophilization and 4 weeks of storage at +4°C (Ia, b; Ila, b; Ilia, b) and (2) storage at -20 Cforafewdays(Ic.d;IIc.d;IIIc.d)were3 4. 13-8 and 53 4. and 3 3. 13-8 and 54-7 nmol/1, respectively. It was concluded that lyophilized plasma samples were stable enough to be used in this study. Figure 1 shows the results ofthe participating laboratories after analysis of the five different samples. One participant was unable to measure histamine in the plasma samples reliably (no. 6: FFEA) and another one had problems with the determination in the aqueous samples (no. 7: RIA).
The imprecision and inaccuracy of the different methods for the measurement of histamine in plasma and aqueous solutions are shown in Fig. 2. Figure 2a is u Youden plot ofthe two unrelated plasma samples I and III. These plasma samples have histamine concentrations that might be defined as pathological (>9 nmol/l) [65] . Concerning the measurement of histamine in plasma, laboratories 3 (ESIA), 8 (RIA) and 10 (HPLC) were inaccurate (outside the circle) and laboratory 3 (ESIA) was also imprecise (outside the parallel lines). Figure 2b is a Youden plot of the two unrelated aqueous histamine solutions. Concerning the measurement of histamine in these samples, laboratories 3 (ESIA), 5 (FFEA), 6 (FFEA) and 10 (HPLC) were inaccurate (outside the circle) and laboratories 3 (ESIA). 6 (FFEA) and 10 (HPLC) were also imprecise (outside the parallel lines). The results of the Youden plots are summarized in Table 3 .
Discussion
In this quality-control study we have attempted lo compare five comonly used histamine assays in different laboratories in Europe for the determination of clinically relevant concentrations of histamine in human plasma (0-45 nmol/l) and aqueous solutions (0-10 nmol/l). For this purpose, lyophilized plasma samples were checked with regard to stability and found to be suitable for use in the present quality control study.
Unfortunately, we were unable to incorporate two EDIAs in this study. Eventually, the two laboratories concerned reported results obtained with other methods, i.e. FFEA and ESIA. Nevertheless., the EDIA method is commonly used and claims good results [29] [30] [31] (Table 1) .
In contrast to Gleieh and Hull [57] , who found great variation of results obtained by different laboratories, this study showed that 7/11 results obtained with the five different methods were accurate, and precise in the plasma range of histamine between 9 and 45 nmol/l (Figs la and Ic, 2a; Table 3 ). The results on plasma II (Fig. Ib: normal plasma pool without addition of external histamine) confirm this observation, although in a Youden plot making use of the results on plasma II from laboratory 8 would just have been accurate, while laboratory 7 would just have been inaccurate. Remarkable in plasma II is the coefficient of variation of 96' >;>, which is much higher than in the other two plasma samples (III: f 7% and I: 11 -6%). However, this high value is in accord with the variation in recently reported reference values between 1980 and 1989 (Table 1:  CV = 67%) . Surprisingly, with respect to measuring histamine in a simple matrix such as aqueous solutions IV and V, less laboratories were precise and accurate (6/11) in comparison with the determination in plasma (7/11) (Figs Id and le, 2b; Table 3 ). This may be due to the lower concentration of histamine in these samples. In correspondence with the results on the plasma samples, the lowest concentrations also showed the greatest variation: CV=I2O%. Only 3/11 laboratories really reported 0 nmol/l in the blank sample IV (Fig. Id) .
In general, estimating concentrations within the normal range seems to be the most difficult part of measuring histamine in human plasma. As in many studies these basal values are the starting point for further investigations and conclusions, this subject requires special attention.
The histamine concentration eventually measured in plasma, while using a certain analytical method, is the result of (1) the 'true" value of circulating plasma histamine in the patient, (2) sample collection and plasma preparation and (3) the analytical method.
(1) Unwanted influence may be caused by the ingestion of histamine-rich food [66] . (2) During sample collection by venepuncture and plasma preparation, histamine may be released from basophilic leucocytes (mainly) and mast cells. This may be caused by: injury, venous stasis, haemolysis, clotting, centrifuging too fast and storage of the blood samples, after collection, for more than 30 min and not on ice [40, 51, 67] . In the past clinical studies have been published in which serum histamine was measured [68, 69] , although, because of complement activation during blood clotting, a histamine value in serum will inform about the number of releasability of basophils rather than about the actual concentration of'free* histamine in blood [40] . (3) Quality-control studies like this can help to solve this problem by evaluating the individual method.
The most recent GCMS and RIA studies suggest a mean reference value for plasma histamine of approximately 1-3 nmol/i [40] [41] [42] , which is confirmed by the linear regression line in the graphical presentation of the reported reference values from 1970 to 1989, as listed in Table I (Fig. 3) . As can be seen' from Table I and Fig. 3 , over the last 20-30 years the reference values have been decreased thanks to more sophisticated methods, and are increasingly able to prevent false interference. Also the problems of sample taking, provoking falsely high results, are better recognized.
Observing the individual accuracy within the five different techniques (Table 3) , it is conceivable that the negative scores ofsome laboratories using FFFA, RIA or HPLC were not due to unreliable methods, but due to problems with the performances at the time of the study. Indications for this are the accurate performances of other laboratories with the same technique and using more or less the same method.
This study revealed the need for further and more extended quality-control studies. Defined reference standards, methods and laboratories for plasma histamine measurements are now required. This seems particularly important because various methods, also applicable to less specialized laboratories, are now on the market or will shortly appear.
